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Effects of blood loss on tissue and serum antibiotic 
levels were investigated in 30 New Zealand white rab- 
bits. Studies were conducted over a 3.5hr period after 
intravenous administration of cefazolin, 30 mg/kg, in 
control animals (Groups I and IV, n = 5 each) and ani- 
mals having 50% (Groups II and V, n = 5 each) or 100% 
(Groups III and VI, n = 5 each) of their blood volume 
removed and replaced with either Ringer’s solution 
(Groups I, II, and III) or rabbit whole blood (Groups IV, 
V, and VI) sufficient to maintain central venous pres- 
sures at baseline levels. Periodic samples of retroperi- 
toneal fat, iliac artery, and serum were assayed for ce- 
fazolin concentration by disc diffusion. Decreased tis- 
sue antibiotic levels were observed in animals 
undergoing 100% blood replacement (Groups III and 
VI) compared to controls (Groups I and IV) in both fat 
(P < 0.01) and artery (P 6 0.01) at 90 min. Decreased 
antibiotic serum half-life accompanying hemorrhage 
existed when comparing Group II to I (P < 0.06)) Group 
III to I (P d O.Ol), and Group IV to V (P < 0.01). The 
increased antibiotic clearance related to blood loss in 
this study justifies reassess ment of intraoperative dos- 
ing intervals. More frequent dosing may be required to 
maintain stable tissue and serum antibiotic levels dur- 
ing substantial operative hemorrhage. a 1891 Academic 
PreM. Inc. 
INTRODUCTION 
Certain surgical infections are catastrophic, and con- 
siderable efforts are directed at their avoidance. Among 
these are prosthetic vascular graft infections, estimated 
to occur in 1 to 6% of arterial reconstructive procedures. 
The use of prophylactic antibiotics in these patients has 
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gained widespread favor and appears justified in reduc- 
ing the risk of infection [l-5]. However, to be effective 
agents for prophylaxis, antibiotics must be present in 
sufficient concentration at potential sites of contamina- 
tion throughout the operation, and such may not always 
be the case during vascular reconstructions. 
Most contemporary perioperative antibiotic dosing 
regimens are derived from pharmacokinetic studies uti- 
lizing either a single dose or constant infusion of antibi- 
otics [6]. Surprisingly little data exist on antibiotic clear- 
ance during shifts in body fluid associated with periods 
of major blood loss and fluid replacement as might occur 
during vascular surgery. It is hypothesized that signifi- 
cant decreases in tissue antibiotic concentration may ac- 
company blood loss and compromise the intended pro- 
phylaxis, as well as fail to counteract the increased sus- 
ceptibility to infection associated with hemorrhagic 
shock [7, 81. The present investigation was undertaken 
to better define the effect of blood loss on antibiotic 
clearance. In particular, tissue and serum cefazolin lev- 
els were assessed in rabbits undergoing controlled hem- 
orrhage and resuscitation. 
METHODS 
Thirty adult New Zealand white rabbits weighing 1.9 
to 3.7 kg were anesthetized with ketamine (40 mg/kg im) 
and xylazine (2.5 mg/kg im), with supplemental keta- 
mine (10 mg/kg im) administered as needed. All animals 
were mechanically ventilated through a tracheotomy. 
External jugular veins and common carotid arteries were 
cannulated with 20-gauge catheters. The jugular cath- 
eters were used for central venous pressure measure- 
ments as well as infusion of antibiotics and fluids. The 
carotid catheters were used for systemic arterial blood 
pressure measurements as well as phlebotomy. Retro- 
peritoneal fat and iliac arteries were exposed through 
midline abdominal incisions. 
Thirty minutes following rapid intravenous bolus in- 
fusion of cefazolin (Ancef, SmithKline & French, Phila- 
delphia, PA), 30 mg/kg, the rabbits were divided into six 
223 0022.4804/91 $1.50 
Copyright 0 1991 by Academic Press, Inc. 
All rights of reproduction in any form reserved. 
224 JOURNAL OF SURGICAL RESEARCH: VOL. 51, NO. 3, SEPTEMBER 1991 
0.0 1.0 2.0 3.0 4.0 5.0 
Serum Protein Concentration (mg/ml) 
FIG. 1. Cefazolin concentration, measured by disc diffusion, as a function of serum protein concentration. Linear regression y = 0.435 
- 0.0555x, r = 0.99, P < 0.001. 
study groups: controls (Groups I and IV, n = 5 each), 
animals bled 50% of their total blood volume (Groups II 
and V, n = 5 each), and animals bled 100% of their total 
blood volume (Groups III and VI, n = 5 each). Total 
blood volume was calculated to be 6% of body weight. 
Central venous pressure was maintained at baseline lev- 
els in this investigation by infusing either warmed 
Ringer’s lactate solution (Groups I, II, and III) or ci- 
trated pooled rabbit whole blood (Groups IV, V, and VI) 
as the replacement fluid during bleeding or as the main- 
tenance fluid in control animals. Retroperitoneal adi- 
pose tissue and arterial blood were sampled hourly 
throughout the study. Five-millimeter-long sections of 








similar sections of right external iliac arteries were re- 
moved at 3.5 hr. In neither circumstance was arterial 
continuity reestablished. Animal care complied with 
standards in The Guide for the Care and Use of Lubora- 
tory Animals (NIH Publication 85-23, revised 1985). 
Antibiotic assays were performed in triplicate using 
disc diffusion methods with 4 hr of incubation at 37°C. 
Weighed tissue specimens were homogenized in dispos- 
able chambers (Fisher Scientific, New York, NY) for 10 
min in 100 ~1 of sterile water. Blood was allowed to stand 
at 25°C for 1 hr and centrifuged at 2000g to obtain 
serum. Twenty-microliter aliquots of tissue homogenate 
or serum were added to 6.35-mm paper discs (Difco, De- 
troit, MI) using disposable pipet tips and placed on 
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FIG. 2. Effect of blood loss on cefazolin concentration in retroperitoneal fat samples. ‘P i 0.01 vs controls (Groups I and IV); tP -z 0.05 vs 
subjects with 50% blood loss (Groups II and V). Error bars represent + standard error of the mean. 
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FIG. 3. Effect of blood loss on cefazolin concentration in iliac artery samples. *P < 0.01 vs controls (Groups I and IV); +P < 0.05 vs subjects 
with 50% blood loss (Groups II and V). Error bars represent + standard error of the mean. 
plates seeded with B. subtilis in antibiotic medium 5 linear regression analysis were utilized in assessing 
(Difco, Detroit, MI). other data as appropriate. 
Standards were prepared with pooled rabbit serum. 
To define minimum assayable tissue concentrations, ce- 
fazolin was added to predetermined quantities of un- 
treated fat or artery and assayed as previously described. 
Additional standards of identical antibiotic concentra- 
tions were also prepared in different dilutions of serum 
to assess effects of protein concentration on assay re- 
sults. Serum protein levels were measured before and 
after resuscitation from hemorrhage. 
RESULTS 
Tissue and serum pharmacokinetic data were ana- 
lyzed using an unpaired t test. x2 one-way ANOVA, and 
Reliable minimum assayable cefazolin tissue concen- 
trations were 1.0 pg/g of fat and 5.0 pg/g of arterial tis- 
sue. These tissue concentration differences may have 
been related to the high protein binding (86%) of cefazo- 
lin, being less in adipose than arterial tissue. Serum ce- 
fazolin concentration determined by disc diffusion 
correlated inversely with serum protein concentration 
(Fig. 1). Therefore, standardization of serum cefazolin 
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FIG. 4. Effect of blood loss on the number of animals with cefazolin detected in retroperitoneal fat samples. ‘P < 0.01 vs controls (Groups I 
and IV). 
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FIG. 5. Effect of blood loss on the number of animals with cefazolin detected in iliac artery samples. *P < 0.01 vs controls (Groups I and 
IV). 
values according to measured serum protein levels was 
important in all half-life calculations of the antibiotic. 
Mean systemic arterial pressures were dissimilar be- 
tween experimental groups and included Group I, 40 
f 12 T (means f standard deviation); Group II, 38 f 12 
T, Group III, 37 + 18 T; Group IV, 80 f 14 T; Group V, 
53 f 16 T; and Group VI, 56 f 12 T. 
Tissue data from animals resuscitated using Ringer’s 
solution and whole blood were combined due to small 
individual group sample sizes. Increases in retroperiton- 
eal fat antibiotic levels comparing controls (Groups I 
and IV) to rabbits undergoing complete blood volume 
replacement (Groups III and VI) were significant (P 
< 0.01) at 1.5 hr (Fig. 2). Similar increases in arterial 
tissue antibiotic levels in controls (Groups I and IV) 
compared to animals bled 100% (Groups III and VI) 
were also significant (P < 0.01) at 1.5 hr (Fig. 3). Differ- 
ences in antibiotic levels at 1.5 hr between Groups V and 
VI did not reach statistical significance in either arterial 
tissue (2.6 pg/g vs 0 pg/g) or adipose tissue (1.6 pg/g vs 0 
I.cg/g). Significant differences in the number of animals 
with detectable antibiotic existed between these same 
animals (Groups I and IV compared to Groups III and 
VI) in both fat (x’, P < 0.01) and arterial tissue (x’, P 
Groups I & IV 
(Control) 
Groups II & V 
(50%) 
Groups 111 & VI 
(100%) 
FIG. 6. Effect of blood loss and manner of resuscitation on cefazolin serum half-life. *P < 0.05 vs controls (Group I); tP < 0.01 vs controls 
(Group I); $P < 0.01 vs subjects with 50% blood loss (Group V). 
BROTHERS ET AL.: HEMORRHAGE AND CEFAZOLIN CLEARANCE 227 
30 40 
Mean Arterial Pressure (mmHg) 
FIG. ‘7. Cefazolin serum half-life in animals bled and resuscitated with Ringer’s solution as a function of the mean arterial pressure. Linear 
regression y = 4.02 - 0.07x, r = 0.81, P < 0.005. 
< 0.01) at 1.5 hr (Figs. 4 and 5). However, no differences 
in fat or artery antibiotic levels occurred at later time 
periods. 
Differences in serum half-life were observed among 
subjects resuscitated with Ringer’s solution comparing 
control animals (Group I) and animals bled 100% of 
their blood volume (Group III, P < O.Ol), as well as in 
comparisons of control animals (Group I) and animals 
bled 50% of their blood volume (Group II, P G 0.05). 
Differences were also observed among subjects resusci- 
tated with whole blood, when comparing animals bled 
50% (Group V) and 100% (Group VI, P < 0.01) of their 
respective blood volume, but not controls (Group IV) 
(Fig. 6). Although not statistically significant, serum 
half-lives of cefazolin were different in the two control 
groups (3.5 f 1.5 hr in Group I and 1.4 -t 0.6 hr in Group 
IV). This difference most likely reflected the lower mean 
arterial blood pressure in the former group. A clear asso- 
ciation existed between antibiotic serum half-life and 
tissue levels for all groups (ANOVA, P < 0.01). 
It is noteworthy that persistence of detectable tissue 
antibiotic at 3.5 hr in both fat (P < 0.01) and artery (P 
< 0.05) samples was inversely related to the rabbit’s 
mean systemic arterial blood pressure, regardless of the 
type of resuscitation. Antibiotic serum half-life follow- 
ing hemorrhage and resuscitation with Ringer’s was also 
inversely related to mean systemic arterial blood pres- 
sure (P < 0.005) (Fig. 7). These data support the tenet 
that low mean arterial pressures are independent pre- 
dictors of diminished antibiotic clearance. It is impor- 
tant to recognize that in this study, mean systemic arte- 
rial pressure was directly related to the degree of blood 
loss (P < O.Ol), so that the lower blood pressures asso- 
ciated with increased blood loss may have caused an un- 
derestimation of the increase in antibiotic clearance 
otherwise observed with increased blood loss. 
DISCUSSION 
Antibiotic prophylaxis in surgical patients is more rel- 
evant to tissue levels than serum levels. In general, tis- 
sue antibiotic levels at sites of potential contamination 
dictate prophylactic efficacy, although this topic contin- 
ues to be debated [9, lo]. Many techniques exist for as- 
sessing antibiotic penetration into tissues, including 
measurements of antibiotic accumulation in intraperito- 
neal perforated containers, subcutaneous fibrin clots, 
subcutaneous Visking chambers, lymphatic duct fluid, 
cutaneous forearm blisters, subcutaneously implanted 
umbilical tape, and homogenized tissue. Utilization of 
the disc diffusion bioassay of antibiotic activity in tissue 
homogenates, a less sensitive technique than liquidchro- 
matography, appears adequate for studies such as the 
present one. In the current investigation, levels of antibi- 
otic were reliably detected within the recommended ther- 
apeutic ranges of four to eight times minimum inhibi- 
tory cefazolin concentrations [l.O-2.0 pg/g for S. aurew] 
[ 111. Although the serum cefazolin concentration corre- 
lated inversely with serum protein concentration, the 
extent of protein binding has been shown to affect nei- 
ther tissue penetration nor the efficacy of an antibiotic 
[12]. In the present study, significant differences in tis- 
sue antibiotic levels were detected only during the first 
1.5 hr after cefazolin administration. This 1.5-hr time 
interval represents the usual half-life of cefazolin under 
stable hemodynamic conditions. Thus, the normal 
serum and tissue clearance of this antibiotic prevents 
detection of significant clearance differences at later pe- 
riods of observation. 
Perioperative use of cephalosporin antibiotics has 
been proven effective in prophylaxis for infection during 
major operations including vascular reconstructions. 
Satisfactory tissue and serum levels for prophylaxis in 
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vascular reconstruction may often be achieved with a 
single preoperative dose of antibiotic [ll, 13, 141. How- 
ever, perioperative antibiotic pharmacokinetics may be 
influenced by multiple factors relevant to clinical prac- 
tice. For example, tissue and serum concentrations at 
the time df graft placement depend on dose timing, with 
ineffective levels present if antibiotic is given too early 
[15]. Little is known about tissue and serum pharmacoki- 
netics in the setting of substantial blood loss and fluid 
resuscitation. On the other hand, serum half-life as well 
as volume of distribution appears increased during some 
vascular operations [ 161. This may, in part, reflect surgi- 
cal trauma and redistribution of body fluids to extravas- 
cular compartments. However, tissue and serum half- 
life of these antibiotics may also-depend upon the 
amount and timing of blood loss during the surgical pro- 
cedure [ 171. A single prospective clinical study of 20 con- 
secutive patients undergoing noncardiac thoracic opera- 
tions attempted to address this issue [18]. In this latter 
study, no correlations between serum cefamandol levels 
and degree of blood loss or replacement were observed. 
However, alteration in blood pressure as a possible inde- 
pendent modifier of antibiotic clearance was not exam- 
ined, and correction for antibiotic variation due to dif- 
ferent serum protein levels was not made in this study. 
The present laboratory investigation clearly demon- 
strates both tissue and serum clearance of antibiotics to 
be altered by hemodynamic conditions similar to those 
that may accompany certain major surgical procedures. 
Loss of more than half the total blood volume causes a 
significant increase in antibiotic clearance and de- 
creases fat and arterial tissue antibiotic levels. These 
data suggest that more frequent dosing in the clinical 
setting may be necessary to maintain adequate tissue 
antibiotic concentration during periods of substantial 
operative blood loss. 
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